We use cookies to provide you with the best possible online experience. Read our cookie policy.
RMB helped Cipla India acquire 100% of Cipla Medpro in a R4.5-bn deal.
In one of the largest single investments by an Indian company on the African continent, RMB is proud to have acted as merchant bank, guarantee provider and FX counterparty for Cipla India’s recent acquisition of 100% of Cipla Medpro South Africa. The deal strengthens Cipla Medpro’s position in South Africa and supports its expansion into Africa, giving the continent access to a wider range of affordable medicines.